Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0015436031
Thu, 27.03.2025
CureVac
CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE
European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 B1 and maintains the patent in amended form
A hearing on infringement of EP 3 708 668 B1 is scheduled for July 1, 2025 [ … ]
Tue, 18.02.2025
CureVac
CureVac Earns Repeat Recognition by LexisNexis® as One of the World’s Top Innovators
CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual property portfolio
The company holds one of the broadest intellectual property portfolios in mRNA techno [ … ]